Evidence map›Paper›PMID 35464888›Full record

ArticleTechnical innovations & patient support in radiation oncology2022

Evaluation of an automated template-based treatment planning system for radiotherapy of anal, rectal and prostate cancer.

Lucie Calmels, Patrik Sibolt, Lina M Åström, Eva Serup-Hansen, Henriette Lindberg, Anna-Lene Fromm, Gitte Persson, David Sjöström, Poul Geertsen, Claus P Behrens

Abstract read
In one paragraph

Article in Technical innovations & patient support in radiation oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Innovative radiotherapy approaches.ESMO gastrointestinal oncology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Physics and imaging in radiation oncology · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lucie CalmelsDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Patrik SiboltDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Lina M ÅströmDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Eva Serup-HansenDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Henriette LindbergDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Anna-Lene FrommDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Gitte PerssonDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
David SjöströmDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Poul GeertsenDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Claus P BehrensDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: The Ethos system has enabled online adaptive radiotherapy (oART) by implementing an automated treatment planning system (aTPS) for both intensity-modulated radiotherapy (IMRT) and volumetric modulated arc radiotherapy (VMAT) plan creation. The purpose of this study is to evaluate the quality of aTPS plans in the pelvic region. Material and Methods: Sixty patients with anal (n = 20), rectal (n = 20) or prostate (n = 20) cancer were retrospectively re-planned with the aTPS. Three IMRT (7-, 9- and 12-field) and two VMAT (2 and 3 arc) automatically generated plans (APs) were created per patient. The duration of the automated plan generation was registered. The best IMRT-AP and VMAT-AP for each patient were selected based on target coverage and dose to organs at risk (OARs). The AP quality was analyzed and compared to corresponding clinically accepted and manually generated VMAT plans (MPs) using several clinically relevant dose metrics. Calculation-based pre-treatment plan quality assurance (QA) was performed for all plans. Results: The median total duration to generate the five APs with the aTPS was 55 min, 39 min and 35 min for anal, prostate and rectal plans, respectively. The target coverage and the OAR sparing were equivalent for IMRT-APs and VMAT-MPs, while VMAT-Aps.demonstrated lower target dose homogeneity and higher dose to some OARs. Both conformity and homogeneity index were equivalent (rectal) or better (anal and prostate) for IMRT-APs compared to VMAT-MPs. All plans passed the patient-specific QA tolerance limit. Conclusions: The aTPS generates plans comparable to MPs within a short time-frame which is highly relevant for oART treatments.

Indexed as

AP, automatically generated planaTPS, automated treatment planning systemAutomated treatment planningCN, conformity numberCT, computed tomographyCTV, clinical target volumeDVH, dose volume histogramFFF, flattening filter freeGTV, gross tumor volumeHI, homogeneity indexIMRT, intensity modulated radiotherapyIntelligent optimization engineKPB, knowledge-based planningLinac, Linear acceleratorsMCO, multi-criteria optimizationMLC, multileaf collimatorMP, manually-generated planMR, magnetic resonanceMU, Monitor UnitOAR, Organ at riskoART, online adaptive radiotherapyOnline adaptive radiotherapyPelvic cancerPlan qualityPTV, planning target volumeQA, Quality assuranceSD, standard deviationTemplate-based Ethos TPSVMAT, volumetric arc radiotherapy

Identifiers

PMID35464888
PMCPMC9020095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.